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We characterized 11 DNA polymerase mutants ofhuman hepatitis B virus (HBV) which contain single missense
or nonsense mutations in the various domains within this gene. Except for mutant 738, a tight association between
DNA replication and RNA packaging of these missense pol mutants was observed. Further analysis ofHBV core
particle-associated RNA indicated that only the 3.5-kb core-specific RNA, but not the precore-specific RNA, is
selectively packaged in this tissue culture system. Previously, we have demonstrated that only the 3.5-kb
core-specific RNA can serve as an efficient template for pol translation. Taken together, our results suggest that
selectivity of HBV RNA packaging occurs as a result of selective translation of pol-containing mRNAs.
Furthermore, our data suggest that the RNA encapsidation domain ofpol overlaps with all of the domains ofpol
involved in the synthesis of terminal protein, as well as DNA replication. Finally, on the basis of gradient
centrifugation analysis, a pol defect appeared to have no negative effect on the assembly or stability of core
particles. A new method to assay RNA encapsidation, as well as potential RNase H activity, is reported.
Similar to retroviruses, hepadnaviruses, including human
hepatitis B virus (HBV), replicate through an RNA interme-
diate (9, 21, 28). RNA-dependent DNA synthesis is mediated
by a virus-encoded gene product (designated Pol) (Fig. 1).
However, unlike retroviruses, the translational strategy of
pol in HBV (12, 23) and duck hepatitis B virus (4, 24) does
not appear to be dependent on ribosomal frameshifting (6).
With cis rescue (23) and trans rescue (4, 24) genetic strate-
gies, it has been demonstrated that translations of pol and
that of its upstream, overlapping nucleocapsid genes (Fig. 1)
appear to be independent from each other.
There are two major HBV-encoded 3.5-kb transcripts that
can potentially serve as mRNA templates for Pol synthesis.
These two different species of 3.5-kb RNA are referred to as
precore- and core-specific mRNAs in this report. The former
initiates approximately 25 to 30 nucleotides 5' upstream from
the latter and is therefore able to synthesize the precore
protein (31, 32). The latter initiates 3' downstream from the
ATG codon of the precore gene and is responsible mainly for
synthesis of the core protein (18, 22). To understand the
translational control of pol better, it is necessary to deter-
mine which 3.5-kb mRNA species is the translational tem-
plate of pol. Using Xenopus oocyte microinjection, as well
as the rabbit reticulocyte lysate in vitro translation system,
we have previously demonstrated that it is the core-specific
mRNA which is a more efficient template for Pol protein
synthesis (17).
Formation of the HBV nucleocapsid involves the complex
association of at least three different components, including
pregenomic RNA, core protein, and DNA polymerase. The
exact sequence of this complicated recognition process
remains unclear. While some reports have proposed that the
pol gene product is required for RNA encapsidation (1, 11),
others have shown that preferential packaging of core-
containing RNA by HBV-encoded core protein can occur in
an overexpressing Escherichia coli system without the pres-
ence of polymerase (2). Whether RNA encapsidation has to
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be mediated via Pol and/or other HBV-specific gene prod-
ucts remains to be clarified.
Using a liver sample from a ground squirrel infected with
ground squirrel hepatitis virus, Enders et al. (7) reported
preferential packaging of core-specific RNA but not precore-
specific RNA in the ground squirrel hepatitis virus animal
model. Since hepadnaviruses are similar to each other in
many respects, it is expected that in the HBV system in
culture, core-specific RNA will probably be encapsidated
selectively. Such selectivity clearly depends on highly spe-
cific protein-RNA interactions. To explore the molecular
basis of the selective encapsidation of core-specific RNA, it
will be necessary to define a domain from the trans-acting
factor which is responsible for recognition of the identified
cis element for RNA packaging (13).
Frameshift and amber linker insertion mutations located at
the various domains of duck hepatitis B virus polymerase
appear to have lost the capability of RNA packaging and
DNA replication (11). Since these mutations are likely to
involve more drastic structural alteration of polymerase, it is
quite possible that the protein-folding pathway or stability
has been severely affected. Therefore, it is difficult to
conclude which specific domain(s) of Pol is required for this
selective RNA encapsidation. To map the domain of pol
responsible for selective RNA encapsidation, it appears to
be more ideal to examine the capability of RNA encapsida-
tion in missense pol mutants with only minimal structural
alteration.
However, one disadvantage of the missense mutation
approach is that missense mutation targets only one amino
acid at a time; unless it happens to hit a critical amino acid in
an effective manner, silent mutation is likely to be the
outcome. For example, Bartenschlager et al. (1) have exam-
ined the RNA-packaging efficiencies of one reverse tran-
scriptase (RT) and four RNase H missense mutants of HBV.
No apparent difference from the wild type was observed.
Similarly, Chang et al. (3) have examined the RNA-packag-
ing efficiencies of one RT and five RNase H missense
mutants of duck hepatitis B virus. No apparent impairment
of RNA encapsidation was found either. The assignment of
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FIG. 1. (a) Transcription map of HBV drawn with a DNA template in a head-to-tail tandem dimer configuration, which represents a
circular permutation of a covalently closed circular form. The four different open reading frames are represented by solid bars. The 3.5-kb
mRNA encodes the precore (PC), core (C), and polymerase (P) proteins of the virus and also serves as a pregenomic RNA template for RT
(see text for a discussion). The 2.5-kb mRNA encodes the presurface antigen (pre-Sl), and the 2.1-kb mRNA encodes another presurface
antigen (pre-S2) and the surface (S) antigen. The polymerase gene (po) is in the + 1 frame with respect to the overlapping nucleocapsid gene
(C), and the X open reading frame encodes a transactivator (27, 30). nt, nucleotides. (b) The diagram represents an amplified version of the
polymerase open reading frame. aa, amino acid; TP, terminal protein. The boundaries of the different domains are tentative. The arrows
indicate the positions of different mutations made in the pol open reading frame. The one-letter amino acid code has been used to show the
structural alteration of missense mutations. TERM indicates introduction of a translational termination codon. (c) Summary of the results of
Southern analysis, polymerase assay (8), and pregenomic RNA encapsidation analysis of HBV pol mutants.
an RNA encapsidation domain to a specific region ofpol can
be greatly facilitated if subtle missense mutation of pol can
lead to a profound encapsidation defectiveness phenotype.
To elucidate the complex association of pregenomic RNA,
core protein, and DNA polymerase better, we analyzed core
particle-associated RNAs from a series of missense point
mutations in various domains of the HBV pol gene (Fig. 1).
Missense mutations in the terminal protein, spacer, and RT
domains of HBV polymerase were found to be deficient in
RNA encapsidation. The relationship among DNA replica-
tion, RNA encapsidation, and pol translation in the life cycle
of HBV is discussed.
MATERIALS AND METHODS
Site-directed mutagenesis and dimerization of HBV DNA.
The procedure for site-directed mutagenesis was adapted
from that of Kunkel (14) and described in detail elsewhere
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TABLE 1. Oligonucleotides used to construct HBV mutants
Nucleotide no. of
mutation position Oligonucleotide sequence 5' to 3"
(HBV aywv)
2310. GAC CAC CAA ACG CCC CTATC
* *
2696. AAG GGT ATT CTA CCT TATTA
*
2787. TTA TAT AAG ATA GAA ACAAC
*
3047. TTT TGG GGT GAA GCC CTCAG
*
60.GTA TTT CCC CGC TGG TGGCT60.......... .....................GTA T
305 .................... CGT GTG TCT TGA CCA AAATT
*
459.GGA CTA TCA GGG TAT GTTGC49........... ..................GA G C
738. GCT TTC AGT CAT ATG GATGA
*
928. GAA CAC ATC AGA CAA AAAAT
*
1183. CTG TGC CAA GAG TTT GCTGA
*
1314. AGC AGG TCT TGA GCA AACAT
a The asterisks indicate positions where base substitutions were introduced
into wild-type HBV.
(23). The oligonucleotides used to construct HBV mutants
are described in Table 1.
To dimerize the HBV genome efficiently, either down-
stream or upstream EcoRI sites of pSV2ANeo-HBV (25)
were eliminated, resulting in a pSV2ANeo-HBV monomer
with either a single upstream EcoRI site (MC-3) or a single
downstream EcoRI site (MC-1). Construction of these plas-
mids and the method of dimerization of mutant HBV DNAs
have been described previously (23). Mutants 2310, 2696,
2787, and 3047 have been cloned into MC-3, while mutants
60, 305, 459, 738, 928, 1183, and 1314 were cloned into
MC-1.
Cell culture and transfection. The human hepatoma cell
line Huh7 was maintained in 10% fetal bovine serum in
Dulbecco modified medium at 37°C in the presence of 5.5%
CO2. The calcium phosphate transfection procedure used
has been detailed elsewhere (25). Briefly, 106 cells per
10-cm-diameter dish were transfected with 10 ,ug of either
wild-type or mutant dimer DNA plus 30 ,ug of human
genomic DNA as the carrier. Donor DNA was removed at
approximately 6 h posttransfection, and cells were fed with
fresh Dulbecco modified medium containing 10% fetal bo-
vine serum.
Isolation of core particles. The procedure used to prepare
intracellular core particles was adapted from Pugh et al. (19)
and Lavine et al. (15). At 5 days posttransfection, cells from
one 10-cm-diameter dish (6 x 106 cells) were lysed at 37°C
for 10 min in 1 ml of buffer containing 10 mM Tris hydro-
chloride (pH 7.5), 1 mM EDTA, 50 mM NaCl, 0.25%
Nonidet P-40, and 8% sucrose. The lysate was then spun in
a microcentrifuge for 2 min, and the supernatant was col-
lected in another tube. The supernatant was made to 8 mM
CaCl2 and 6 mM MgCl2, followed by digestion with 30 U of
micrococcal nuclease and 1 U of DNase 1 for 15 min at 37°C.
The crude core particles were precipitated by adding 330 ,ul
of 26% polyethylene glycol (molecular weight, 8,000) in 1.5
M NaCl and 60 mM EDTA. After incubation for 1 h at 4°C,
the crude core particles were pelleted by being spun in a
microcentrifuge for 4 min.
Preparation of RNA. The RNA isolation method used was
that of Chomczynski and Sacchi (5). Briefly, the core pellet
was first dissolved in 0.1 ml of denaturation solution (4 M
guanidine thiocyanate, 25 mM sodium citrate, 0.5% sarco-
syl, 0.1 M 2-mercaptoethanol). Following dissolution, 0.01
ml of 2 M sodium acetate (pH 4.0), and 0.1 ml of water-
saturated phenol were added, each time with mixing of the
solution by inversion. Finally, 0.02 ml of a chloroform-
isoamyl alcohol mixture (49:1) was added and vortexed for
10 s. The whole mixture was put on ice for 15 min and then
centrifuged for 15 min at 4°C. The resulting aqueous phase
was collected in another tube, and RNA was precipitated by
adding an equal volume of isopropanol. For isolation of total
RNA, cells from one 10-cm-diameter dish were lysed in 2 ml
of denaturation solution and the volumes of the rest of the
solutions were adjusted accordingly.
DNase and RNase digestion of core-associated RNA. Core-
associated RNA isolated from one 10-cm-diameter dish was
digested with either 15 U of RNase-free DNase (Boehringer
Mannheim Co.) for 15 min at 37°C or a mixture of 40 jig of
RNase A per ml and 20 p.g of RNase Ti per ml for 30 min at
37°C. After digestion, the DNase-digested sample was phe-
nol extracted and ethanol precipitated. The RNase-digested
sample was made 0.5% with sodium dodecyl sulfate and then
digested with proteinase K (0.125 mg/ml) for 15 min at 37°C.
The RNA was then phenol extracted and ethanol precip-
itated.
Primer extension analysis. A 5'-end-labeled 22-nucleotide
synthetic oligonucleotide (nucleotides 1980 to 2001) was
used as a primer. Approximately 105 cpm (0.1 pmol) was
lyophilized with core-associated RNA isolated from one
10-cm-diameter dish. The dried pellet was dissolved in 30 ,ul
of hybridization buffer containing 40 mM PIPES [piperazine-
N,N'-bis(2-ethanesulfonic acid)] (pH 6.4), 400 mM NaCl, 1
mM EDTA, and 80% formamide and allowed to anneal at
30°C overnight. After annealing, 170 IL1 of 0.3 M sodium
acetate and 500 RI1 of ethanol were added for precipitation.
The washed and dried pellet was then dissolved in 24 ,u1 of
reverse transcription buffer (50 mM Tris hydrochloride [pH
8.3], 6 mM MgCl2, 100 mM NaCl, 10 mM dithiothreitol, a 0.4
mM four-deoxynucleoside triphosphate mixture, 50 p.g of
dactinomycin per ml, 10 U of human placental RNase
inhibitor [BRL]) and incubated with 12 U of avian myelo-
blastosis virus RT (Molecular Genetic Resources Inc.) for 90
min at 42°C. The reaction was terminated by addition of 1 p.1
of 0.5 M EDTA, and the RNA was digested with 1 p.g of
pancreatic RNase A for 30 min at 37°C. A 100-,ul volume of
2.5 M ammonium acetate was then added, followed by
phenol extraction and ethanol precipitation. The washed and
dried pellet was dissolved in 3 p.1 of TE (10 mM Tris
hydrochloride [pH 7.5], 1 mM EDTA), and 4 p.1 of loading
buffer (80% formamide, 1 mM EDTA, 0.1% bromophenol
blue, 0.1% xylene cyanol) was added. A 3-,ul portion of each
sample was analyzed on a 6% polyacrylamide sequencing
gel.
Sedimentation and density gradient analysis of intracellular
core particles. Cells transfected with either wild-type or
mutated HBV dimer DNA were lysed in 0.5 ml of chilled
extraction buffer (20 mM Tris hydrochloride [pH 7.4], 7 mM
MgSO4, 50 mM NaCl, 0.1% 2-mercaptoethanol, 100 p.g of
bovine serum albumin per ml, 0.25 M sucrose) with a
Dounce homogenizer. The homogenate was cleared by spin-
ning in a microcentrifuge for 15 min at 4°C. The cleared
homogenate was then loaded either on a sucrose gradient (5
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FIG. 2. Primer extension analysis of core-associated RNA shows strong association between HBV pol defects and RNA packaging. Core-
associated RNA from one 10-cm-diameter dish was used for each sample. Size markers were prepared by using the same primer in a
sequencing reaction with an HBV wild-type (WT) DNA template. The arrowhead indicates the calculated position of the extended product
of the core-specific transcript. The nucleotide number on the top of each lane indicates the position of the base changed (Fig. lb). (b)
Packaging-defective HBV pol mutants express all three major transcripts of HBV. At 5 days posttransfection, cells from one-half of a 10-cm-
diameter dish were harvested and total cellular RNA was prepared while core-associated RNA was isolated from the other half as described
in Materials and Methods. Twenty micrograms of total RNA, as well as core-associated RNAs isolated from one-half of a 10-cm-diameter
dish, was used for Northern blot analysis. The three major HBV-specific transcripts are indicated on the left. Mutants 2787, 60, and 1183 were
assayed by primer extension only, while mutants 305 and 459 were assayed by Northern blotting only. (c) DNase and RNase sensitivity of
core-associated RNA. Core-associated RNA isolated from one 10-cm-diameter dish transfected with wild-type HBV DNA was subjected to
either RNase-free DNase I (Boehringer Mannheim Co.) or RNase digestion as described in Materials and Methods and analyzed by Northern
blot analysis.
ml of 15 to 30% [wt/vol] sucrose in extraction buffer) or a
cesium chloride gradient (5 ml of 20 to 50% cesium chloride
in 10 mM Tris hydrochloride [pH 7.5], 150 mM NaCl, 1 mM
EDTA). The sucrose gradients were run at 32,000 rpm for 6
h at 4°C in a Beckman SW50.1 rotor. The cesium chloride
gradients were run at 35,000 rpm for 16 h at 4°C in a
Beckman SW50.1 rotor. Fractions (200 ,ul) were collected
from the bottom of the gradient. Alternate fractions were
used for core-e antigen analysis with a kit from Abbott
Laboratories. Sucrose fractions were used for assay di-
rectly, while cesium chloride fractions were desalted by
dialysis through an Amicon filter (type 10) with four changes
of buffer.
Northern (RNA) blot analysis. RNA samples were dena-
tured with glyoxal and then run on a 1% agarose gel (16).
RNAs were then transferred to a nylon membrane filter and
probed with a vector-free 32P-labeled full-length HBV DNA
fragment.
RESULTS
As shown in Fig. 2, upon transfection of the tandem dimer
of the HBV mutant genomes into Huh7 hepatoma cells, we
analyzed the total RNA and the core particle-associated
RNA prepared from the transfected culture by primer exten-
sion and Northern blot analysis.
Analysis of encapsidated RNA by primer extension. Mu-
tants 2310, 2696, 2787, 60, 928, and 1314 exhibited no
detectable signals of encapsidated RNA by primer extension
analysis (Fig. 1 and 2a). In contrast, the wild type, as well as
mutants 3047, 738, and 1183, whose mutations are in the
spacer, RT, and RNase H domains, respectively, exhibited
detectable levels of encapsidated RNA (Fig. 1 and 2a). The
signal was RNA template specific, since the primer exten-
sion reactions were performed in the presence of dactino-
mycin (50 jig/ml). Furthermore, the primer-extended prod-
uct resulted in a band at a position corresponding to the
known 5' initiation sites of the 3.5-kb core-specific mRNA
(31, 32), rather than to the 5' end of the short (+) strand of
HBV DNA.
Analysis of encapsidated RNA by Northern blot. Another
way to assay core particle-associated RNA is by Northern
blot analysis. As shown in Fig. 2b, all of the mutants
exhibited significant levels of HBV-specific total RNA (8).
However, only mutants 3047, 459, and 738 exhibited detect-
able levels of encapsidated 3.5-kb RNA. Mutants 2310, 2696,
305, 928, and 1314 exhibited no detectable signal of encap-
sidated RNA despite having a total HBV-specific RNA level
that appeared to be similar to that of the wild type. In a
control experiment, when an exogenous RNA marker was
mixed, before RNA extraction, with the core particles
isolated from pol mutants, discrete RNA marker signals
were observed on a Northern blot (26). Therefore, the
smearing signals of the encapsidated HBV RNA in the wild
type and mutants 3047, 459, and 738 (Fig. 2b) are more likely
due to the degradation activity of Pol-associated RNase H
during the process of DNA replication (for details, see the
Discussion) rather than contamination of other species of
HBV-specific RNAs and artifactual degradation during ex-
perimental manipulations.
These encapsidated RNA signals as detected by Northern
analysis are resistant to RNase-free DNase (Boehringer
Mannheim Co.) digestion and sensitive to DNase-free
RNase digestion (Fig. 2c), suggesting that they are indeed of
RNA origin. The results from Northern blot analysis (Fig.
2b) appear to be consistent with those from primer extension
(Fig. 2a). Taken together, they show that mutants 3047, 459,
738, and 1183 are competent to encapsidate the pregenomic
RNA, indicating that structural alterations in these positions
are tolerable. In contrast, subtle missense mutants 2310,
2696, 2787, 60, and 928 and nonsense mutants 305 and 1314
apparently have lost the ability for pregenomic RNA pack-
aging.
Selective packaging of core-specific RNA. Our primer ex-
tension results (Fig. 2a) indicate that only the core-specific
mRNA, not the precore-specific mRNA, is packaged. How-
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FIG. 3. Selective packaging of core-specific 3.5-kb RNA demonstrated by primer extension analysis using three different HBV-producing
cell lines. Q7HBV-21 is a high-titer HBV-producing hepatoma cell line (25). UP7-4 and UP7-8 are two independent clones obtained by stable
transfection of the HepG2 human hepatoma cell line (26). Approximately 50 p.g of total RNA (one-fifth of a 10-cm-diameter dish) and one-half
of the core-associated RNA from a 10-cm-diameter dish, approximately 1 day postconfluence for Q7HBV-21 and 10 days postconfluence for
UP7-4 and UP7-8, were used for primer extension analysis. T represents total RNA, and C represents core-associated RNA. The open arrow
indicates the position of the extended product from the core-specific transcript, and the solid arrowhead indicates that of the precore-specific
transcript. (b) Approximately 10 to 20% of HBV core-specific RNA is selectively packaged. Total and core-associated RNAs were each
isolated from one 10-cm-diameter dish of Q7HBV-21 cells (25). Aliquots of 1/2, 1/4, 1/8, and 1/16 of the total RNA and 1/2 of the
core-associated RNA were quantitatively compared by primer extension analysis.
ever, it is possible that the level of the precore-specific RNA
is too low to be detectable in transient transfection assays.
We therefore analyzed the total intracellular, as well as
particle-associated, HBV-specific RNAs prepared from sev-
eral stable HBV-producing cell lines of rat Morris hepatoma
and human HepG2 hepatoblastoma origins (25). As shown in
Fig. 3, although the precore-specific mRNA was rather
abundant in the total intracellular RNA fraction of cell line
Q7HBV-21, weakly detectable in UP7-8, and undetectable in
UP7-4, we were unable to detect any encapsidated precore-
specific RNA, even in the Q7HBV-21 cell line.
Quantitation of the packaging efficiency of core-specific
RNA. The selective packaging (Fig. 3a) and selective trans-
lation ofpol (17) from the same core-specific mRNA species
suggest potential competition for the core-specific mRNA
between translation and packaging. Quantitation of the per-
centage of encapsidated core-specific RNA would help to
address this issue.
In HBV-producing HepG2 cell lines (eg., UP7-4 and
UP7-8 in Fig. 3a), HBV replication appears to increase with
time after the cell density has reached confluence (26, 29).
To avoid confusion from this phenomenon of aging-depen-
dent HBV replication in HBV-producing HepG2 cell lines,
we used instead a system of an HBV-producing Morris
hepatoma cell line (25) for quantitation of encapsidated
pregenomic RNA. Significant levels of HBV transcription
and replication can be easily detected in this system, even
before the cell density has reached confluence. Since the
experiment shown in Fig. 3a was not performed in a quan-
titative manner, as shown in Fig. 3b, a more quantitative
comparison of core-specific mRNA between the particle-
associated fraction and the total intracellular pool in
Q7HBV-21 (25) demonstrated that approximately 10 to 20%
of the core-specific mRNA is encapsidated (Fig. 3b).
Sedimentation and buoyant density gradient analysis of core
particles. Although the results shown in Fig. 2 are consistent
with involvement of the Pol protein in encapsidation (11), an
alternative explanation suggests an overall decrease in the
yield of subviral core particles produced by these pol mu-
tants without changing the specific packaging efficiency per
viral particle. To differentiate between these two possibili-
ties, we compared the core-e antigens in the medium be-
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FIG. 4. Sedimentation and density gradient analysis indicate no apparent effect of pol mutation on core particle assembly. Intracellular
core particles from one 10-cm-diameter dish transfected with 5 ,ug of respective mutant or wild-type DNA were subjected to either sucrose
density gradient (a) or cesium chloride gradient (b) centrifugation. Alternative fractions were used for core-e antigen analysis as recommended
by the manufacturer.
tween the mutants and the wild type (26). In addition, when
the intracellular incompletely matured subviral particles
from both wild-type and mutant transfected cultures were
analyzed by sucrose and cesium chloride gradient centrifu-
gation, equivalent levels of core particles, as analyzed by a
semiquantitative enzyme immunoassay of core-e antigen,
were observed to peak at the same position (ca. 1.34 g/ml)
(Fig. 4). The same level of intracellular core protein between
the wild type and mutants has also been observed when
immunoprecipitation with rabbit anti-core polyclonal anti-
body was performed (26). The material banding at 1.2 g/ml is
most likely intracellular nascent Dane particles on their way
out to be secreted into the medium.
DISCUSSION
General correlation between DNA replication and RNA
encapsidation. When we compared these RNA encapsidation
results (Fig. 2) with the results of DNA replication and
polymerase activity associated with these point mutants of
pol (8), a good but not perfect correlation was evident (Fig.
1). Although the signals of encapsidated RNA in mutants 459
(Fig. 2b) and 3047 (Fig. 2a and b) are relatively weaker than
that of the wild type, the mutants are clearly positive in RNA
encapsidation. All three mutants (3047, 459, and 1183) com-
petent in RNA encapsidation also are capable of DNA
replication (8; Fig. 1). Similarly, all seven mutants defective
in RNA encapsidation also fail to perform DNA replication
and exhibit no polymerase activity (8; Fig. 1).
Requirement of polymerase in RNA packaging. The corre-
lation between DNA replication and RNA encapsidation
could be due to a number of reasons. It may be that (i) the
encapsidation signal is ablated by the mutations, (ii) the
stability of the pregenomic RNA is altered by the mutations;
(iii) the synthesis, stability, or assembly of the nucleocapsid
is impaired by the mutations; (iv) replication is a prerequisite
of encapsidation; or (v) a functional Pol protein is required
for both replication and encapsidation.
The cis element on the pregenomic RNA responsible for
packaging has been mapped to a narrow region near its 5'
end (13). A short segment of 85 nucleotides from the cis
element is sufficient for encapsidation of heterologous non-
viral RNA (13). As shown in Fig. 1, all of the point mutations
introduced into the pol gene of HBV are located outside the
b
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encapsidation signal. Therefore, the failure of those pol-
defective mutants to perform RNA packaging (Fig. 2) is not
due to fortuitous mutational perturbation of the cis element
of encapsidation. Additionally, the steady-state levels of
HBV-specific RNA transcribed by these mutants (except
mutant 3047) appear to be similar to the wild-type level (Fig.
2b). Furthermore, there is no apparent effect of these pol
mutations on the synthesis or stability of core protein or
particles (Fig. 4; see also discussions below). Finally, we
consider it highly unlikely that efficient DNA replication, if it
is a prerequisite to RNA encapsidation, can take place
before complete formation of the nucleocapsid. We prefer
the interpretation which suggests that the RNA encapsida-
tion defectiveness phenotype is due to a defect of a trans-
acting pol gene product required for DNA replication, as
well as RNA encapsidation.
Assay for RNA encapsidation and potential RNase H activ-
ity. As shown in the Northern blot of Fig. 2b and c,
HBV-specific, RNase-sensitive signals can be detected from
core particle-associated RNA. The smearing pattern of en-
capsidated HBV-specific RNAs of mutants 3047, 459, and
738 and the wild type suggests that it is likely due to
processive degradation of the RNA moiety from 3' to 5' by
polymerase-associated RNase H activity. A control experi-
ment done by adding an exogenous RNA reference marker
to the polyethylene glycol-isolated core particles before
RNA extraction (see Materials and Methods) indicates that
the exogenous RNA marker remains intact throughout the
procedures of RNA preparation (26). We cannot rule out the
possibility that core-associated pregenomic RNA was de-
graded by cellular RNase before addition of RNA extraction
buffer. It would be very helpful if we could examine the
encapsidated RNA from an RNase H mutant which is
positive in RNA packaging and defective in RNase H
activity, as reported by Radziwill et al. (20).
Mutant 738: uncoupling between replication and encapsida-
tion. RT domain mutant 738 contains a missense substitution
which changes the most-conserved YMDD motif into
HMDD (Fig. 1). This mutant does not appear to exhibit any
normal DNA replicative intermediates on Southern blot
analysis, nor does it contain any detectable polymerase
activity (8). However, its RNA encapsidation activity ap-
pears to be similar to or higher than that of the wild type.
One RNase H missense mutant (designated P4) and one
RT missense mutant (designated P2) reported by Barten-
schlager et al. (1) were found to be polymerase activity
defective yet packaging positive. Similarly, in the duck
hepatitis B virus system, Chang et al. (3, 11) have reported
RT and RNase H mutants that are defective at DNA
synthesis but encapsidation competent. Our results of mu-
tant 738 appear to substantiate these reports (1, 3, 11) that
DNA replication and RNA encapsidation are uncouplable
events.
Coupling between RNA encapsidation and Pol translation.
Previously, we have demonstrated that the core-specific
mRNA, but not the precore-specific mRNA, can serve as a
good template for Pol translation (17). Selective packaging
(Fig. 3a) and selective translation of Pol suggest that trans-
lation and packaging of Pol are two intimately coupled
events. The essence of this hypothesis is that translation and
packaging are cooperative rather than competing events. On
the basis of asymmetric complementation results, cis pref-
erence of pregenomic RNA packaging has been proposed
(11). This phenomenon is consistent with the hypothesis that
translation and packaging of Pol are tightly coupled.
The targeting strategy of most retroviral polymerase is to
form a Gag-Pol fusion protein through ribosomal frameshift-
ing (6, 10). In hepadnaviruses, translation of Pol appears to
be independent of core protein synthesis (4, 12, 23, 24). This
hypothesis that translation and packaging of polymerase are
coupled events in hepadnaviruses is particularly appealing,
since it offers an explanation of how trace amounts of Pol
protein and pregenomic RNA can be brought into proximity
for productive RNA-protein interaction and packaging.
Effect of pol mutation on production and assembly of core
particles. Although the results reported here, as well as those
from others (1, 3, 11), indicate that the pol gene product is
required for RNA packaging, a recent report (2) indicates
that HBV-specific core protein expressed in E. coli at a
nonphysiologically high concentration can preferentially
package core protein RNA in the absence of any HBV-
specific Pol protein. The apparent discrepancy concerning
whether polymerase is required for HBV pregenomic RNA
encapsidation can be explained if the failure of Pol encapsi-
dation is due to a negative effect of pol mutation on the
synthesis or stability of core protein or on the assembly or
stability of core particles.
This interpretation was tested as shown in Fig. 4. Neither
the number nor the sedimentation value and density of core
particles appeared to alter significantly in our Pol-defective
mutants. Our gradient analysis results (Fig. 4) suggest that
the morphogenesis of both core particles and Dane particles
can take place even in the absence of encapsidated RNA, a
functional pol gene product, or a binary complex between
RNA and polymerase. In addition, the defect of pol has no
apparent direct or indirect effect on core protein expression
as analyzed by immunoprecipitation (26).
Encapsidation and replication domains of Pol overlap ex-
tensively. As shown in Fig. 1 and 2, four different missense
mutations within the pol gene, with a single amino acid
substitution, resulted in failure of DNA replication, as well
as RNA encapsidation. These four mutations include pre-
sumably subtle structural alterations in the terminal protein
domain (mutants 2696 and 2787), the spacer (mutant 60), and
the RT domain (mutant 928). In addition, mut ion 1314
within the RNase H domain causes failure to p kage the
pregenomic RNA. Therefore, it is possible th; all four
domains of Pol are required for packaging. Considering
protein with a three-dimensional structure, it is perhaps not
surprising that the RNA encapsidation and DNA replication
domains of Pol are highly overlapped and were therefore
difficult to dissociate (see the data summarized in Fig. 1).
Alternatively, the Pol protein may be exceedingly sensitive
to any subtle conformational change which may lead to
improper protein folding and loss of replication, as well as
packaging activity. Although this conclusion appears to be
consistent with that of Bartenschlager et al. (1), it remains to
be shown whether it is also true of other hepadnaviruses.
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